Dergiler / Turkish Neurosurgery / 2016 / Cilt: 26 - Sayı: 4

Effect of Simvastatin on Proliferation of Vascular Smooth Muscle Cells During Delayed Cerebral Vasospasm After Subarachnoid Hemorrhage

Sayfa
538–544
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

CONCLUSION: Simvastatin may relieve dCVS after SAH by inhibiting the proliferation of VSMCs.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:AIM: To explore the effect of simvastatin on proliferation of vascular smooth muscle cells (VSMCs) during delayed cerebral vasospasm (dCVS) after subarachnoid hemorrhage (SAH).
📊
Temel Bulgular & Veri:MATERIAL and METHODS: Thirty-six male New Zealand White rabbits were randomly divided into three groups: 1) Control group (n=12): given conventional breeding and normal sodium (0.9%) was injected twice into the cisterna magna. 2) SAH group (n=12): given conventional breeding and a SAH model was established. 3) Simvastatin + SAH group (n=12): given conventional breeding and simvastatin for one week, and then a SAH model was established.
💡
Sonuç & Katkı:CONCLUSION: Simvastatin may relieve dCVS after SAH by inhibiting the proliferation of VSMCs.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

AIM: To explore the effect of simvastatin on proliferation of vascular smooth muscle cells (VSMCs) during delayed cerebral vasospasm (dCVS) after subarachnoid hemorrhage (SAH). MATERIAL and METHODS: Thirty-six male New Zealand White rabbits were randomly divided into three groups: 1) Control group (n=12): given conventional breeding and normal sodium (0.9%) was injected twice into the cisterna magna. 2) SAH group (n=12): given conventional breeding and a SAH model was established. 3) Simvastatin + SAH group (n=12): given conventional breeding and simvastatin for one week, and then a SAH model was established. The first cerebral angiography was conducted before the first injection of sodium or autologous blood into the cisterna magna. The second angiography was done three days after the second injection. The ultrastructural pathology of the basilar artery was compared in three groups. The expression of platelet-derived growth factor-? (PDGF-?), proliferating cell nuclear antigen (PCNA) and ?-smooth muscle actin (?-SMA) in VSMCs was analysed by RT-PCR.RESULTS: Angiography examinations showed that the basilar artery was obviously contracted in the SAH group and dCVS was confirmed existence after blood injection into the cisterna magna twice. The thickness of VSMCs in the SAH group increased and the expression of PDGF-?, PCNA, and ?-SMA in SAH group were all increased compared to the control group (p<0.05), and decreased while prophylactic giving simvastatin (p<0.05). CONCLUSION: Simvastatin may relieve dCVS after SAH by inhibiting the proliferation of VSMCs.

🔖

Bu Makaleye Atıf Yap

DUAN, H., ZHANG, J., LI, L., BAO, S. (2016). Effect of Simvastatin on Proliferation of Vascular Smooth Muscle Cells During Delayed Cerebral Vasospasm After Subarachnoid Hemorrhage. Turkish Neurosurgery, Cilt: 26 - Sayı: 4, 538–544. https://ajindex.com/articles/404666

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Baggott CD, Aagaard-Kienitz B: Cerebral vasospasm. Neurosurg Clin N Am 25: 497-528, 2014 2. Chaterji S, Lam CH, Ho DS, Proske DC, Baker AB: Syndecan-1 regulates vascular smooth muscle cell phenotype. PLoS One 9:e89824, 2014 3. Chen D, Chen JJ, Yin Q, Guan JH, Liu YH: Role of ERK1/2 and vascular cell proliferation in cerebral vasospasm after experimental subarachnoid hemorrhage. Acta Neurochir (Wien) 151:1127-1134, 2009 4. Chen J, Dai M, Wang Y: Paeonol inhibits proliferation of vascular smooth muscle cells stimulated by high glucose via Ras-Raf-ERK1/2 signaling pathway in coculture model. Evid Based Complement Alternat Med 2014:484269, 2014 5. Cheng MF, Song JN, Li DD, Zhao YL, An JY, Sun P, Luo XH: The role of rosiglitazone in the proliferation of vascular smooth muscle cells after experimental subarachnoid hemorrhage. Acta Neurochir (Wien) 156:2103-2109, 2014 6. Chou SH, Smith EE, Badjatia N, Nogueira RG, Sims JR 2nd, Ogilvy CS, Rordorf GA, Ayata C: A randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage. Stroke 39:2891-2893, 2008 7. Cui HK, Yan RF, Ding XL, Zhao P, Wu QW, Wang HP, Qin HX, Tu JF, Yang RM: Platelet-derived growth factor-? expression in rabbit models of cerebral vasospasm following subarachnoid hemorrhage. Mol Med Rep 10:1416-1422, 2014 8. Danura H, Schatlo B, Marbacher S, Kerkeni H, Diepers M, Remonda L, Fathi AR, Fandino J: Acute angiographic vasospasm and the incidence of delayed cerebral vasospasm: Preliminary results. Acta Neurochir Suppl 120:187-190, 2015 9. Kolias AG, Sen J, Belli A: Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: Putative mechanisms and novel approaches. J Neurosci Res 87:1-11, 2009 10. Kolovou GD, Katerina A, Ioannis V, Cokkinos DV: Simvastatin: Two decades in a circle. Cardiovasc Ther 26:166-178, 2008 11. Lynch JR1, Wang H, McGirt MJ, Floyd J, Friedman AH, Coon AL, Blessing R, Alexander MJ, Graffagnino C, Warner DS, Laskowitz DT: Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: Results of a pilot randomized clinical trial. Stroke 36:2024-2026, 2005 12. McGirt MJ, Pradilla G, Legnani FG, Thai QA, Recinos PF, Tamargo RJ, Clatterbuck RE: Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm. Neurosurgery 58:945-951, 2006 13. Sakowitz OW, Unterberg AW: Detecting and treating microvascular ischemia after subarachnoid hemorrhage. Curr O